Table 4.
Normal (n=6) |
Control (n=6) |
CSB Activation (n=8) |
|
---|---|---|---|
GADPH (du) | 0.34 ± 0.02 | 0.35 ± 0.03 | 0.36 ± 0.02 |
β1-Adrenergic Receptor (du) | 0.55 ± 0.06 | 0.26 ± 0.04* | 0.51 ± 0.08† |
β2-Adrenergic Receptor (du) | 0.23 ± 0.03 | 0.26 ± 0.04 | 0.25 ± 0.03 |
β-Adrenergic Receptor Kinase (du) | 0.27 ± 0.05 | 1.22 ± 0.08* | 0.54 ± 0.06*† |
Adenylyl Cyclase (du) | 0.64 ± 0.05 | 0.34 ±0.04* | 0.53 ± 0.06*† |
Angiotensinogen (du) | 0.36 ± 0.05 | 0.74 ± 0.06* | 0.39 ± 0.03† |
eNOS (du) | 0.71 ± 0.07 | 0.44 ± 0.07* | 0.56 ± 0.07*† |
iNOS (du) | 0.34 ± 0.06 | 0.72 ± 0.06* | 0.43 ± 0.05*† |
GADPH = glyceraldehyde-3-phosphate dehydrogenase ; eNOS = endothelial nitric oxide synthase. iNOS – inducible nitric oxide synthase ;
=p<0.05 vs. Normal,
=p<0.05 vs. Control.